Global Recombinant Vaccine Market Analysis 2016-2020 and Forecast 2021-2026
Global Recombinant Vaccine Market Analysis 2016-2020 and Forecast 2021-2026
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Recombinant Vaccine market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Recombinant Vaccine by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Merck & Co., Inc.
Green Cross Corporation
Pfizer, Inc.
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc
Novartis AG
Bharat Biotech
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Human
Animal
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Recombinant Vaccine Industry
Figure Recombinant Vaccine Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Recombinant Vaccine
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Recombinant Vaccine
1.2.2 Downstream
Table Application Segment of Recombinant Vaccine
Table Global Recombinant Vaccine Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Recombinant Vaccine Market by Type
3.1 By Type
3.1.1 Subunit Recombinant Vaccines
Table Major Company List of Subunit Recombinant Vaccines
3.1.2 Attenuated Recombinant Vaccines
Table Major Company List of Attenuated Recombinant Vaccines
3.1.3 Vector Recombinant Vaccines
Table Major Company List of Vector Recombinant Vaccines
3.2 Market Size
Table Global Recombinant Vaccine Market 2016-2020, by Type, in USD Million
Figure Global Recombinant Vaccine Market Growth 2016-2020, by Type, in USD Million
Table Global Recombinant Vaccine Market 2016-2020, by Type, in Volume
Figure Global Recombinant Vaccine Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Recombinant Vaccine Market Forecast 2021-2026, by Type, in USD Million
Table Global Recombinant Vaccine Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Merck & Co., Inc. (Company Profile, Sales Data etc.)
4.1.1 Merck & Co., Inc. Profile
Table Merck & Co., Inc. Overview List
4.1.2 Merck & Co., Inc. Products & Services
4.1.3 Merck & Co., Inc. Business Operation Conditions
Table Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Green Cross Corporation (Company Profile, Sales Data etc.)
4.2.1 Green Cross Corporation Profile
Table Green Cross Corporation Overview List
4.2.2 Green Cross Corporation Products & Services
4.2.3 Green Cross Corporation Business Operation Conditions
Table Business Operation of Green Cross Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Pfizer, Inc. (Company Profile, Sales Data etc.)
4.3.1 Pfizer, Inc. Profile
Table Pfizer, Inc. Overview List
4.3.2 Pfizer, Inc. Products & Services
4.3.3 Pfizer, Inc. Business Operation Conditions
Table Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Sanofi S A. (Company Profile, Sales Data etc.)
4.4.1 Sanofi S A. Profile
Table Sanofi S A. Overview List
4.4.2 Sanofi S A. Products & Services
4.4.3 Sanofi S A. Business Operation Conditions
Table Business Operation of Sanofi S A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Protein Science Corporation (Company Profile, Sales Data etc.)
4.5.1 Protein Science Corporation Profile
Table Protein Science Corporation Overview List
4.5.2 Protein Science Corporation Products & Services
4.5.3 Protein Science Corporation Business Operation Conditions
Table Business Operation of Protein Science Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
4.6.1 GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Overview List
4.6.2 GlaxoSmithKline Plc Products & Services
4.6.3 GlaxoSmithKline Plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Novartis AG (Company Profile, Sales Data etc.)
4.7.1 Novartis AG Profile
Table Novartis AG Overview List
4.7.2 Novartis AG Products & Services
4.7.3 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Bharat Biotech (Company Profile, Sales Data etc.)
4.8.1 Bharat Biotech Profile
Table Bharat Biotech Overview List
4.8.2 Bharat Biotech Products & Services
4.8.3 Bharat Biotech Business Operation Conditions
Table Business Operation of Bharat Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Recombinant Vaccine Sales Revenue 2016-2020, by Company, in USD Million
Table Global Recombinant Vaccine Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Recombinant Vaccine Sales Revenue Share in 2020, by Company, in USD Million
Table Global Recombinant Vaccine Sales Volume 2016-2020, by Company, in Volume
Table Global Recombinant Vaccine Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Recombinant Vaccine Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Recombinant Vaccine Market Concentration, in 2020
Figure Europe Recombinant Vaccine Market Market Concentration, in 2020
Figure Asia-Pacific Recombinant Vaccine MMarket Concentration, in 2020
Figure South America Recombinant Vaccine Market Concentration, in 2020
Figure Middle East & Africa Recombinant Vaccine Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Human
Figure Recombinant Vaccine Demand in Human, 2016-2020, in USD Million
Figure Recombinant Vaccine Demand in Human, 2016-2020, in Volume
6.1.2 Demand in Animal
Figure Recombinant Vaccine Demand in Animal, 2016-2020, in USD Million
Figure Recombinant Vaccine Demand in Animal, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Recombinant Vaccine Demand Forecast 2021-2026, by Application, in USD Million
Figure Recombinant Vaccine Market Growth 2021-2026, by Application, in USD Million
Figure Recombinant Vaccine Market Share in 2026, by Application, in USD Million
Table Recombinant Vaccine Demand Forecast 2021-2026, by Application, in Volume
Table Recombinant Vaccine Market Growth 2021-2026, by Application, in Volume
Table Recombinant Vaccine Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Recombinant Vaccine Production 2016-2020, by Region, in USD Million
Table Recombinant Vaccine Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Recombinant Vaccine Market 2016-2020, by Region, in USD Million
Table Global Recombinant Vaccine Market Share 2016-2020, by Region, in USD Million
Table Global Recombinant Vaccine Market 2016-2020, by Region, in Volume
Table Global Recombinant Vaccine Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure North America Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table North America Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure Europe Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table Europe Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure South America Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table South America Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Recombinant Vaccine Market Forecast 2021-2026, by Region, in USD Million
Table Recombinant Vaccine Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Research Methodology:
Recombinant Vaccine Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|